Journal
PEDIATRIC INFECTIOUS DISEASE JOURNAL
Volume 41, Issue 1, Pages E25-+Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/INF.0000000000003389
Keywords
mRNA COVID-19 vaccine; myopericarditis; adolescents Accepted for publication October 10; 2021
Categories
Funding
- National Ministry of Higher Education and Science [0237-00004B]
Ask authors/readers for more resources
A nationwide study in Denmark found that the incidence of myopericarditis after Pfizer-BioNTech mRNA COVID-19 vaccination was higher among males aged 12-17 years compared to reports from the United States.
In this prospective nationwide multicenter study from Denmark, myopericarditis after Pfizer-BioNTech mRNA COVID-19 vaccination was identified in 13 males and 2 females between May 15 and September 15, 2021, among 133,477 vaccinated males and 127,857 vaccinated females 12-17 years of age, equaling 97 males and 16 females per million. In conclusion, the incidence of myopericarditis after COVID-19 vaccination among males appears higher than reports from the United States.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
